๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion

๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion

Share this post

๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
Poolbeg Pharma Plc

Poolbeg Pharma Plc

Positive Results from POLB 001 LPS Human Challenge Trial

๐Ÿ Elric Langton's avatar
๐Ÿ Elric Langton
Mar 02, 2023
โˆ™ Paid

Share this post

๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
Poolbeg Pharma Plc
Share

SPONSORED

By Elric Langton | 2 March 2023

I have a financial interest in Poolbeg Pharma.

Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a leading infectious disease-focused biopharmaceutical company, announcโ€ฆ

This post is for paid subscribers

Already a paid subscriber? Sign in
ยฉ 2025 ๐Ÿ“ˆ ๐Ÿ Small Company Champion - Small Company Media Ltd
Privacy โˆ™ Terms โˆ™ Collection notice
Start writingGet the app
Substack is the home for great culture

Share